A food science journal has retracted a French study linking genetically modified foods to tumors and organ failure in rats that went viral on the Internet. Elsevier, the publisher of the journal, Food and Chemical Toxicity, said it was ...
An environmental lobby group in Europe has criticised car makers for failing to fit particulate filters to vehicles powered by direct injection petrol engines, quoting research that reveals they emit up to 1000 times more particles than ...
Tags: Petrol Engines, Older Engines
US-basedd VuCOMP has announced that M-Vu CAD, the first mammography CAD product clinically proven in a pivotal reader study, is available as a companion technology for the Siemens MAMMOMAT Inspiration PRIME Edition, MAMMOMAT Inspiration, ...
Tags: Healthcare, Health, Medicine
Navidea Biopharmaceuticals will collaborate with the University of Alabama at Birmingham (UAB) on a clinical study that will assess the safety and activity of a radiolabeled, humanized monoclonal antibody from its RIGS (radio-immuno-guided ...
Novogen, a biotechnology company, has announced the filing of a family of provisional patents in the US covering anti-tropomyosin (ATM) drug technology. ATM drugs represent an entirely novel approach to anti-cancer therapy, blocking the ...
VBL Therapeutics has secured fast track status from the US Food and Drug Administration (FDA) for its lead oncology drug VB-111, for prolongation of survival in patients with Recurrent Glioblastoma Multiforme (rGBM). VB-111 was already ...
US-based research and development biotechnology firm Boston Strategics has entered into a new drug development partnership with Fujifilm Pharmaceuticals USA (FPHU), a global pharmaceutical development center of Japan's Fujifilm Corporation. ...
Tags: Oncology Drugs, Fujifilm Pharma
Agalimmune, a biopharmaceutical company, has been created to develop innovative immunotherapeutics for the treatment of cancer, with a focus on solid tumours. The new company has been founded by an investment group comprising Loxbridge ...
Tags: solid tumours, cancer treatment
A research paper published in the scientific journal Tobacco Control shows that graphic warning labels on cigarette packs led to a decrease in smoking rates in Canada of between 12% and 20% from 2000 to 2009. The authors estimate that if ...
Prostate cancer stem cells evolve into different cells as the disease progresses and this becomes a moving target for treatment, U.S. researchers say. Drs. Andrew Goldstein, Owen Witte and Tanya Stoyanova and colleagues at the University ...
Tags: prostate cancer, stem cell, evolve, change, treatment, harder
Dan Peters, owner of Lancaster Bicycle, passed away Nov. 22 after a long battle with cancer. He was 41. Before opening Lancaster Bicycle four years ago, Peters managed Bike Source in Columbus and at one time worked for Kenda as a sales ...
Tags: Ohio, retailer, industry, veteran, Dan Peters, pass away
Shannon's winning "Live Beautifully" Pinterest board. In support of Susan G. Komen, Mohawk commemorated National Breast Cancer Awareness Month with two consumer-based social media contests. The contests were designed to engage consumers ...
Tags: Mohawk Break Cancer, awareness, Month Contest, winner, announced
Posted in Testing Services by Chris Newmarker on November 25, 2013 The FDA is telling 23andMe to stop marketing its Personal Genomic Service tests. The FDA’s move is but another sign that the regulator is increasingly concerned ...
Tags: 23andMe, DNA, Hit, FDA, warning letter
A look back through our archives sees that DuPont, Dr Pepper, Post Holdings and Ralcorp Holdings, Kraft Foods and Dow Chemical Company have all had issues to address. General Mills is working to undo the impact of poor waste disposal more ...
Tags: Changing, environmental, issue, food, firm
Men with prostate cancer who ate a low-fat diet and took fish body oil supplements may have lower risk of cancer recurrence, U.S. researchers say. Lead author William Aronson of the University of California, Los Angeles, and chief of ...
Tags: Low-fat, diet, fish oil, supplement, prostate, cancer, recurrence